PATRICK BURCHETTE

Meetings and communications with RUS regarding loan applications and general approvals; WRDA Section 2014.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing; Medicare Part B reimbursement policies relating to clinical diagnostic testing; generally support Section 216 of Protecting Access to Medicare Act (H.R. 4302) relating to adjustments to the Medicare Clinical Laboratory Fee Schedule; oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Affordable Care Act and its impact on clinical laboratories and laboratory personnel; legislation concerning regulation of laboratory-developed diagnostic tests.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; generally support Section 216 of Protecting Access to Medicare Act (H.R. 4302) relating to adjustments to the Medicare Clinical Laboratory Fee Schedule; oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Affordable Care Act and its impact on clinical laboratories and laboratory personnel; legislation concerning regulation of laboratory-developed diagnostic tests.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Affordable Care Act and its impact on clinical laboratories and laboratory personnel; legislation concerning regulation of laboratory-developed diagnostic tests.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Affordable Care Act and its impact on clinical laboratories and laboratory personnel; legislation concerning regulation of laboratory-developed diagnostic tests.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207); support Taking Essential Steps for Testing Act (H.R. 6118; S.3391).

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDS initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207); support taking essential steps for Testing Act (H.R. 6118; S. 3391).

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reductions to Medicare Clinical Laboratory Fee Schedule.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207).

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reduction to Medicare Clinical Laboratory Fee Schedule in the Middel Class Tax Relief and Job Creation Act of 2012 (H.R. 3630).

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207).

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing. Oppose reduction to Medicare Clinical Laboratory Fee Schedule in the Middel Class Tax Relief and Job Creation Act of 2012 (H.R. 3630).

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests; legislation concerning regulation of laboratory-developed diagnostic tests (including H.R. 3207).

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Congressional initiatives to implement the Budget Control Act of 2011 as related to Medicare reimbursement for clinical laboratory testing.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Oppose requirement for physician signature on test requisitions.

Oppose proposals to require beneficiary coinsurance for Medicare clinical laboratory testing. Medicare Part B reimbursement policies relating to clinical diagnostic testing; Oppose requirement for physician signature on test requisitions

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel FDA initiatives to regulate laboratory-developed diagnostic tests

Medicare Part B reimbursement policies relating to clinical diagnostic testing; Oppose requirement for physician signature on test requisitions

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests.

H.R. 4853, that passed both houses of Congress; specifically, the window and door provisions of Sec. 710, Credit for Nonbusiness Energy Property.

House and Senate versions of H.R. 4213, Section 611 & 211; all provisions related to modification of standards for windows, doors and skylights with respect to the credit for non-business energy property; Home Star provisions of S. 3663, the Clean Energy Jobs and Oil Company Accountability Act.

RUS Financing

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel; FDA initiatives to regulate laboratory-developed diagnostic tests.

RUS Financing

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel.

S. 1792, a bill to amend the Internal Revenue Code of 1986 to modify the requirements for windows, doors and skylights to be eligible for the credit for non-business energy property,all providsions related to the requirements; H.R., 4112, (same as S. 1792); House and Senate versions of H.R. 4213, Section 611 & 211; all provisions related to modification of standards for windows, doors and skylights with respect to the credit for non-business energy property.

S. 1792, a bill to amend the Internal Revenue Code of 1986 to modify the requirements for windows, doors and skylights to be eligible for the credit for non-business energy property, all provisions related to the requirements; H.R. 4112 (same as S. 1792); H.R. 4213, American Workers, State and Business Relief Act of 2010, Section 611; all provisions related to modification of standards for windows, doors and skylights with respect to the credit for non-business energy property.

H.R. 5019, Home Star Energy Retrofit Act of 2010, Sec. 5(b) Energy Savings Measures; provisions related to windows, doors, skylights; S. 3177, Home Star Energy Retrofit Act of 2010, Sec. 7(b) Energy Savings Measures; provisions related to windows, doors, skylights; S. 3079, Building Star Energy Efficient Act of 2010, Sec. 2 Definitions and Sec. 3(b) Rebates; provisions related to windows, doors and related measures.

H.R. 5019, Home Star Energy Retrofit Act of 2010, Sec. 5(b) Energy Savings Measures; provisions related to windows, doors, skylights; S. 3177, Home Star Energy Retrofit Act of 2010, Sec. 7(b) Energy Savings Measures; provisions related to windows, doors, skylights; S. 3079, Building Star Energy Efficient Act of 2010, Sec. 2 Definitions and Sec. 3(b) Rebates; provisions related to windows, doors, and related measures.

S.1792, a bill to amend the Internal Revenue Code of 1986 to modify the requirements for windows, doors and skylights to be eligible for the credit for non-business enery property, all provisions related to the requirements; H.R. 4112 (same as S. 1792); H.R. 4213, American Workers, State, and Business Relief Act of 2010, Section 611; all provisions related to modification of standards for windows, doors and skylights with respect to the credit for non-business energy property.

RUS Financing

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel.

Meetings and communications with Congressional staff regarding re-allocation of water from Denison Dam.

Healthcare Reform Legislation and its impact on clinical laboratories and laboratory personnel.

S.1792, a bill to amend the Internal Revenue Code of 1986 to modify the requirements for windows, doors and skylights to be eligible for the credit for non-business energy property, all provisions related to the requirements. H.R. 4112; to amend the Internal Revenue Code of 1986 to modify the requirements for windows, doors and skylights to be eligible for the credit for non-business energy property, all provisions related to the requirements.

Tax credits and other energy efficiency programs related to the building industry (S. 1792 and H.R. 4112).

Tax credits and other energy efficiency programs related to the building industry (S. 1792 and H.R. 4112).

Tax credits and other energy efficiency programs related to the building industry (S. 1792 and H.R. 4112).

Medicare Clinical Diagnostic Laboratory Fee Schedule (interested in H.R. 1452)

Healthcare Reform legislation and its impact on clinical laboratories and laboratory personnel.

Interested in any legislation that calls for mandatory caps on powerplant emissions. Interested in Carbon Legislation.

Interested in any provisions in appropriations legislation impacting the Rural Utilities Service, rural electric cooperative, and the Power Marketing Administrations. Interseted in Stimulus Package that relates to energy and water.

Meetings with RUS re: loans.

Interested in any legislation that calls for mandatory caps on power plant emissions. Denison Dam water reallocation. Carbon legislation.

Interested in any provisions in appropriateions legislation impacting hte Rural Utilities Service, rural electric cooperatives, and the Power Marketing Administration. Interested in Stimulus Package that relates to energy and water.

All issues pertaining to greenhouse gas regulations as it affects electric power generation. Interested in any legislation that calls for mandatory caps on power plant emissions. Interested in all impacts on rural electric cooperatives. Denison Dam water reallocation.

Meeting with RUS re: loans. Interested in Climate Change Legislation. Interested in Carbon Legislation.

Meeting with RUS re: loans. Interested in Climate Change legislation. Interested in Carbon legislation.

Interested in any provisions in appropriations legislation impacting the Rural Utilities Service, rural electric cooperatives, and the Power Marketing Administration. Interested in Stimulus Package that relates to energy and water.

All issues pertaining to greenhouse gas regulations as it affects electric power generation. Interested in any legislation that calls for mandatory caps on power plant emissions. Interested in all impacts on rural electric cooperatives. Denison dam water reallocation

Medicare Clinical Diagnostic Labratory Fee Schedule (interested in H.R.1452)

Healthcare Reform legislation and its impact on clinical labratories and labratory personnel.

Interested in any legislation that calls for mandatory caps on power plant emissions. Denison dam water reallocation. Carbon legislation.

Interested in any legislation that calls for mandatory caps on power plant emissions. Denison dam water reallocation. Carbon legislation.

Meetings with RUS re: loans.

Interested in any provisions in appropriations legislation impacting the Rural Utilities Service, rural electric cooperatives, and the Power Marketing Administrations. Interested in Stimulus Package that relates to energy and water.

Interested in any legislation that calls fo mandatory caps on powerplant emissions. Interested in Carbon legislation.

Interested in any provisions in appropriations legislation impacting the Rural Utilities Service, rural electric cooperatives, and the Power Marketing Administration. Interested in Stimulus Package that relates to energy and water.

All issues pertaining to greenhouse gas regulations as it affects electric power generation. Interested in any legislation that calls for mandatory caps on power plant emissions. Interested in all impacts on rural electric cooperatives. Denison dam water reallocation

Meeting with RUS re: loans. Interested in Climate Change legislation. Interested in Carbon legislation.

Medicare Clinical Diagnostic Labratory Fee Schedule (interested in H.R.1452)

Healthcare Reform legislation and its impact on clinical labratories and labratory personnel.